Cover Image
市場調查報告書

多工化驗的全球市場的預測 ∼2021年:各產品、類型 (核酸為基礎的、蛋白質為基礎的)、技術 (PCR、平面陣列)、用途、終端用戶

Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 365315
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
Back to Top
多工化驗的全球市場的預測 ∼2021年:各產品、類型 (核酸為基礎的、蛋白質為基礎的)、技術 (PCR、平面陣列)、用途、終端用戶 Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User - Global Forecast to 2021
出版日期: 2016年08月01日 內容資訊: 英文 174 Pages
簡介

多工化驗市場在預測期間內預計以7.2%的年複合成長率 (CAGR) 發展,從2016年的26億6000萬美元,成長到2021年37億6000萬美元的規模。

本報告提供全球多工化驗的市場調查,市場及技術概要,對市場成長的各種影響因素與市場機會分析,產品、類型、技術、用途、終端用戶產業、地區等各種區分的趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 地區市場實際成果:各產品與服務
  • 地區市場概要
  • 各終端用戶市場
  • 各類型市場

第5章 多工化驗的全球市場:概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 多工化驗的全球市場:各產品與服務

  • 簡介
  • 消耗品
  • 設備
  • 配件
  • 軟體、服務

第7章 多工化驗的全球市場:各類型

  • 簡介
  • 核酸為基礎的
    • 平面核酸化驗
    • 微珠核酸化驗
  • 蛋白質為基礎的
    • 平面蛋白化驗
    • 微珠蛋白質化驗

第8章 多工化驗的全球市場:各技術

  • 簡介
  • 多工PCR
  • 多工陣列
    • 多重平面陣列
    • 多重微珠陣列
  • 其他

第9章 多工化驗的全球市場:各用途

  • 簡介
  • R&D
    • 藥物開發
    • 生物標記的發現、驗證
  • 疾病、異常
    • 感染疾病
    • 癌症
    • 心臟疾病
    • 自體免疫疾病
    • 老年癡呆症
    • 過敏
  • 搭配診斷
  • 其他

第10章 多工化驗的全球市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 學術、研究機關
  • 臨床實驗室
  • 醫院
  • 其他

第11章 多工化驗的全球市場:地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 競爭環境

  • 概要
  • 競爭情形、趨勢
    • 新產品的投入
    • 協定、合作、聯盟
    • 收購
    • 其他

第13章 企業簡介

  • 簡介
  • LUMINEX CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • ILLUMINA, INC.
  • BIO-RAD LABORATORIES INC.
  • QIAGEN N.V.
  • ABCAM PLC
  • BECTON, DICKINSON AND COMPANY
  • MERCK KGAA
  • SEEGENE INC.
  • MESO SCALE DIAGNOSTICS, LLC.
  • RANDOX LABORATORIES LTD.
    • 概要
    • 產品與服務
    • 策略
    • 發展趨勢
    • 分析師的考察等

第14章 附錄

目錄
Product Code: BT 4473

Adoption of Companion Diagnostics for Increasing Efficacy of Therapies, Advantages of Multiplexing Over Traditional Assays, and Need for Effective Analytical Platforms in Research to Reduce Operational Costs, and Will Boost the Growth of the Multiplex Assays Market.

The multiplex assays market is projected to reach USD 3.76 billion by 2021 USD 2.66 billion in 2016, growing at a CAGR of 7.2% during the forecast period (2016-2021). In this report, the multiplex assays market is broadly segmented on the basis of product & service, type, technology, applications, end user, and region.

The multiplex assays market, based on the type, is categorized into nucleic acid-based assays and protein-based assays. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays. The protein based assays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to adoption of these assays in research purpose. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. Based on the technology, the multiplex assays market is categorized into multiplex polymerase chain reaction, multiplex arrays, and other technologies. The multiplex arrays segment is further divided into planar arrays and bead-based arrays. The multiplex arrays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to technological advancements emerging in this segment.

The U.S. is expected to account for the largest share of the multiplex assays market in 2016. Europe is the second-largest source for multiplex assays market; this regional market is driven by the availability of government funds for the research and development of multiplex assays. Asia-Pacific region is estimated to be the fastest growing region in the multiplex assays market during the forecast period due to the adoption of multiplex assays in this region.

New product launches is the dominant strategy adopted by key industry participants in the multiplex assays market to increase their market share and cater to unmet needs.

Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).

Reasons to Buy the Report:

This research report has focused on various levels of analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth market segments; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on multiplex assays products and services offered by the top players in the global multiplex assays market
  • Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the multiplex assays market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for multiplex assays across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global multiplex assays market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the leading players in the global multiplex assays market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
    • 2.2.3. ASSUMPTIONS FOR THE STUDY
    • 2.2.4. REPORT LIMITATIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. MULTIPLEX ASSAYS: MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL ANALYSIS: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES (2016)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET
  • 4.4. MULTIPLEX ASSAYS MARKET, BY END USER
  • 4.5. MULTIPLEX ASSAYS MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Adoption of companion diagnostics for increasing safety & efficacy of therapies
      • 5.3.1.2. Need for effective analytical platforms to reduce operational costs
      • 5.3.1.3. Advantages of multiplexing over traditional assays
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High investment cost of multiplex assay equipment
      • 5.3.2.2. Standardization of immunoassay design and quality control
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Increasing validation of biomarkers in molecular and protein diagnostics
      • 5.3.3.2. Need for high-throughput and automated systems
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Dearth of skilled labor
      • 5.3.4.2. Development of assays for all disease classes

6. MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICES

  • 6.1. INTRODUCTION
  • 6.2. MULTIPLEX ASSAY CONSUMABLES
  • 6.3. MULTIPLEX ASSAY INSTRUMENTS
  • 6.4. MULTIPLEX ASSAY ACCESSORIES
  • 6.5. SOFTWARE AND SERVICES

7. MULTIPLEX ASSAYS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
    • 7.2.1. PLANAR NUCLEIC ACID ASSAYS
    • 7.2.2. BEAD-BASED NUCLEIC ACID ASSAYS
  • 7.3. PROTEIN-BASED MULTIPLEX ASSAYS
    • 7.3.1. PLANAR PROTEIN ASSAYS
    • 7.3.2. BEAD-BASED PROTEIN ASSAYS

8. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. MULTIPLEX PCR
  • 8.3. MULTIPLEX ARRAYS
    • 8.3.1. MULTIPLEX PLANAR ARRAYS
    • 8.3.2. MULTIPLEX BEAD-BASED ARRAY
  • 8.4. OTHER TECHNOLOGIES

9. GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH & DEVELOPMENT
    • 9.2.1. DRUG DEVELOPMENT
    • 9.2.2. BIOMARKER DISCOVERY AND VALIDATION
  • 9.3. DISEASES & DISORDERS
    • 9.3.1. INFECTIOUS DISEASES
    • 9.3.2. CANCER
    • 9.3.3. CARDIAC DISEASES
    • 9.3.4. AUTOIMMUNE DISEASES
    • 9.3.5. ALZHEIMER'S DISEASE
    • 9.3.6. ALLERGIES
  • 9.4. COMPANION DIAGNOSTICS
  • 9.5. OTHER APPLICATIONS

10. MULTIPLEX ASSAYS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. ACADEMIC & RESEARCH INSTITUTES
  • 10.4. CLINICAL LABORATORIES
  • 10.5. HOSPITALS
  • 10.6. OTHER END USERS

11. GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
  • 11.4. ASIA-PACIFIC
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. COMPETITIVE SITUATION AND TRENDS
    • 12.2.1. NEW PRODUCT LAUNCHES
    • 12.2.2. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.2.3. ACQUISITION
    • 12.2.4. OTHER STRATEGIES

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. LUMINEX CORPORATION
  • 13.3. THERMO FISHER SCIENTIFIC INC.
  • 13.4. ILLUMINA, INC.
  • 13.5. BIO-RAD LABORATORIES INC.
  • 13.6. QIAGEN N.V.
  • 13.7. ABCAM PLC
  • 13.8. BECTON, DICKINSON AND COMPANY
  • 13.9. MERCK KGAA
  • 13.10. SEEGENE INC.
  • 13.11. MESO SCALE DIAGNOSTICS, LLC.
  • 13.12. RANDOX LABORATORIES LTD.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 2: GLOBAL MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: GLOBAL MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL MULTIPLEX ASSAY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL MULTIPLEX ASSAY ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NORTH AMERICA: MULTIPLEX ASSAY ACCESSORIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2016-2021 (USD MILLION)
  • TABLE 15: GLOBAL PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL BEAD-BASED NUCLEIC ACID ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NORTH AMERICA: PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL PLANAR PROTEIN ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL BEAD-BASED PROTEIN ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL MULTIPLEX PCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: MULTIPLEX PCR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL MULTIPLEX ARRAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL MULTIPLEX ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MULTIPLEX ARRAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL PLANAR ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: PLANAR ARRAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL BEAD-BASED ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: BEAD-BASED ARRAYS MARKET SIZE, BY COUNTRY, 2016-2021 (USD MILLION)
  • TABLE 36: GLOBAL OTHER TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: OTHER TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2016-2021 (USD MILLION)
  • TABLE 38: GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL MULTIPLEX ASSAYS DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MULTIPLEX ASSAYS DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL MULTIPLEX ASSAYS BIOMARKER DISCOVERY & VALIDATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: MULTIPLEX ASSAYS BIOMARKER DISCOVERY & VALIDATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR INFECTIOUS DISEASES APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR INFECTIOUS DISEASES APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CANCER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CANCER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CARDIAC DISEASES APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CARDIAC DISEASES APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR AUTOIMMUNE DISEASES APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR AUTOIMMUNE DISEASES APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR ALZHEIMER'S DISEASE APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ALZHEIMER'S DISEASE APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR ALLERGIES APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ALLERGIES APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR COMPANION DIAGNOSTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 64: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 66: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: GLOBAL MULTIPLEX ASSAY MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CLINICAL LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR OTHERS END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 78: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 84: U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 86: U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 88: CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 89: CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 92: CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 93: EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 94: EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 96: EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 98: ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 99: ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 101: ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 103: ROW: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 104: ROW: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: ROW: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 106: ROW: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 107: ROW: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 108: NEW PRODUCT LAUNCHES, 2016
  • TABLE 109: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2015 & 2016
  • TABLE 110: ACQUISITIONS, 2014-2016
  • TABLE 111: OTHER STRATEGIES, 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: MULTIPLEX ASSAYS MARKET
  • FIGURE 2: MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH
  • FIGURE 3: MULTIPLEX ASSAYS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: MULTIPLEX ASSAYS MARKET SIZE, BY END USERS, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: MULTIPLEX ASSAYS MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 14: RISING FOCUS ON REDUCING OPERATIONAL COSTS-PRIMARY GROWTH DRIVER OF THE MULTIPLEX ASSAYS MARKET FROM 2016-2021
  • FIGURE 15: CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 16: APAC WILL BE THE FASTEST-GROWING MARKET FROM 2016 TO 2021
  • FIGURE 17: PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2021
  • FIGURE 18: NUCLEIC ACID-BASED ASSAYS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 19: MULTIPLEX ASSAYS MARKET SEGMENTATION
  • FIGURE 20: GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21: CONSUMABLES SEGMENT TO DOMINATE THE MULTIPLEX ASSAYS PRODUCT AND SERVICES MARKET DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 22: NORTH AMERICA TO DOMINATE MULTIPLEX ASSAY CONSUMABLES MARKET IN THE FORECAST PERIOD 2016-2021
  • FIGURE 23: THE PROTEIN MULTIPLEX ASSAYS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 24: THE U.S IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE NORTH AMERICAN NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 25: NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PLANAR NUCLEIC ACID ASSAYS MARKET DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 26: THE U.S. IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BEAD-BASED NUCLEIC ACID ASSAYS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 27: NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PROTEIN-BASED MULTIPLEX ASSAYS MARKET DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 28: THE U.S IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PLANAR PROTEIN ASSAYS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 2016-2021
  • FIGURE 29: MULTIPLEX ARRAYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 30: PLANAR ARRAYS TECHNOLOGY SEGMENT TO ACCOUNT FOR MORE THAN HALF OF THE MULTIPLEX ARRAYS MARKET IN 2016
  • FIGURE 31: NORTH AMERICA TO HOLD THE MAJOR SHARE IN THE PLANAR ARRAY TECHNOLOGY MARKET (2016-2021)
  • FIGURE 32: THE RESEARCH & DEVELOPMENT APPLICATION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD, 2016-2021
  • FIGURE 33: NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS DURING THE FORECAST PERIOD, 2016-2021
  • FIGURE 34: NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR DISEASE & DISORDER APPLICATIONS DURING THE FORECAST PERIOD, 2016-2021
  • FIGURE 35: NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR COMPANION DIAGNOSTICS DURING THE FORECAST PERIOD, 2016-2021
  • FIGURE 36: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE MULTIPLEX ASSAYS MARKET, 2016-2021
  • FIGURE 37: NORTH AMERICA FORMS THE LARGEST SEGMENT IN THE MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2016-2021
  • FIGURE 38: U.S. TO DOMINATE THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET FOR CLINICAL LABORATORIES, 2016-2021
  • FIGURE 39: NORTH AMERICAN MARKET FOR HOSPITALS TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD, 2016-2021
  • FIGURE 40: GEOGRAPHIC SNAPSHOT (2016): ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION BY 2021
  • FIGURE 41: NORTH AMERICA PROVIDES GROWTH OPPORTUNITIES FOR THE MULTIPLEX ASSAYS MARKET, 2016
  • FIGURE 42: NORTH AMERICAN MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 43: R&D SEGMENT TO DOMINATE THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2021
  • FIGURE 44: U.S. MULTIPLEX BEAD ARRAYS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR IN THE MARKET, BY TECHNOLOGY, 2016-2021
  • FIGURE 45: EUROPE MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 46: NUCLEIC ACID-BASED ASSAYS TO HOLD THE LARGEST SHARE IN THE EUROPEAN MARKET, BY TYPE, 2016-2021
  • FIGURE 47: PHARMA & BIOTECH SEGMENT EXPECTED TO COMMAND LARGEST SHARE IN THE APAC END-USER MARKET, 2016-2021
  • FIGURE 48: COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY BETWEEN 2014-2016
  • FIGURE 49: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES-THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE MULTIPLEX ASSAYS MARKET FROM 2014-2016
  • FIGURE 50: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS, 2015
  • FIGURE 51: LUMINEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
  • FIGURE 53: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 54: COMPANY SNAPSHOT: BIO-RAD LABORATORIES INC.
  • FIGURE 55: COMPANY SNAPSHOT: QIAGEN N.V.
  • FIGURE 56: ABCAM PLC: COMPANY SNAPSHOT
  • FIGURE 57: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 58: COMPANY SNAPSHOT: MERCK KGAA
  • FIGURE 59 COMPANY SNAPSHOT: SEEGENE INC.
Back to Top